BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, June 20, 2026
Home
»
Topics
»
Drugs
» Immuno-oncology
Immuno-oncology
RSS
Preliminary phase I data for Revimid show activity against solid tumors, good safety
June 8, 2001
Berlex commences launch of Campath in U.S.
June 7, 2001
Herceptin reaches market in Japan
June 5, 2001
Topical immune response modifier provides high response rate in phase II trial in sBCC
June 5, 2001
European authorities grant orphan drug designation for pemtumomab
June 5, 2001
Wilex antibody receives orphan drug status for RCC from FDA
June 1, 2001
Oxxon Pharmaccines begins melanoma pharmaccine trials
May 30, 2001
Avicine may be as effective as traditional chemotherapy in pancreatic cancer
May 29, 2001
Neose Technologies and BMS amend cancer vaccine collaboration
May 29, 2001
CancerVax therapeutic vaccine significantly increases survival in late-stage cancers
May 22, 2001
Previous
1
2
…
932
933
934
935
936
937
938
939
940
…
1009
1010
Next